Zerun Biotechnology Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
13
- Investments
-
1
Zerun Biotechnology General Information
Description
Developer of recombinant human vaccines designed for protecting people from infectious diseases. The company utilizes s protein trimer technology and CHO cell expression systems to produce bivalent hpv vaccines, recombinant COVID-19 vaccines, multi-variant vaccine candidates, prototype vaccine candidates, and recombinant human vaccines, enabling healthcare providers to access stable antigen proteins for enhanced immune response.
Contact Information
Website
www.zerunbio.com(Operating Subsidiary)
Corporate Office
- Building 9, Lane 1690, Zhangheng Road, Zhangjiang District
- Pudong
- Shanghai, 201203
- China
Corporate Office
- Building 9, Lane 1690, Zhangheng Road, Zhangjiang District
- Pudong
- Shanghai, 201203
- China
Zerun Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Zerun Biotechnology Comparisons
Industry
Financing
Details
Zerun Biotechnology Competitors (3)
One of Zerun Biotechnology’s 3 competitors is Hummingbird Bioscience, a Venture Capital-Backed company based in Singapore, Singapore.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hummingbird Bioscience | Venture Capital-Backed | Singapore, Singapore | ||||
| AUM Biosciences | Venture Capital-Backed | Singapore, Singapore | ||||
| KM Biologics | Accelerator/Incubator Backed | Kumamoto, Japan |
Zerun Biotechnology Patents
Zerun Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023165435-A1 | Recombinant spike protein, method for preparing same and use thereof | Inactive | 01-Mar-2022 | ||
| WO-2023116374-A1 | Herpes zoster vaccine composition | Inactive | 23-Dec-2021 | ||
| WO-2022089233-A1 | Recombinant spike protein, and preparation method therefor and application thereof | Inactive | 30-Oct-2020 | ||
| WO-2009132484-A1 | Lytic proteins of vero cell, preparation method thereof and detection kit for vero hcp comprising the same | Inactive | 30-Apr-2008 | ||
| US-20110256182-A1 | Genes encoding major capsid protein l1 of human papilloma virus | Active | 23-Nov-2007 | C07K14/025 |
Zerun Biotechnology Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Zerun Biotechnology Investments (1)
Zerun Biotechnology’s most recent deal was a Corporate with Yidao Bio. The deal was made on 08-Jun-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Yidao Bio | 08-Jun-2018 | Corporate | Drug Discovery |
Zerun Biotechnology Exits (1)
Zerun Biotechnology’s most recent exit was on 08-Jun-2018 from Yidao Bio. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Yidao Bio | 08-Jun-2018 | Completed |
|
Zerun Biotechnology FAQs
-
When was Zerun Biotechnology founded?
Zerun Biotechnology was founded in 2003.
-
Where is Zerun Biotechnology headquartered?
Zerun Biotechnology is headquartered in Shanghai, China.
-
What industry is Zerun Biotechnology in?
Zerun Biotechnology’s primary industry is Drug Discovery.
-
Is Zerun Biotechnology a private or public company?
Zerun Biotechnology is a Private company.
-
What is Zerun Biotechnology’s current revenue?
The current revenue for Zerun Biotechnology is .
-
How much funding has Zerun Biotechnology raised over time?
Zerun Biotechnology has raised $8.15M.
-
Who are Zerun Biotechnology’s investors?
Green Living Equity Investment Fund, Tibet Jinsheng Shuoxing Capital, and Xinyu Fanglue Dehe Investment Management have invested in Zerun Biotechnology.
-
Who are Zerun Biotechnology’s competitors?
Hummingbird Bioscience, AUM Biosciences, and KM Biologics are competitors of Zerun Biotechnology.
-
When was Zerun Biotechnology acquired?
Zerun Biotechnology was acquired on 26-Jun-2026.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process